Stocks
›
Press Release
Advertise
USD
EN
App
Download App
Crypto
Stocks
Forex
Metals
Portfolio
Exchanges
Token Sales
News
Tools
Hotspot
Close
Home
Stocks
INVA
News
Market Closed
INVA
Innoviva
$ 19.03
0.32%
Last 24H
Trading with leverage comes with a high risk and may not be suitable for everyone.
Trading with leverage comes with a high risk and may not be suitable for everyone.
Watchlist
Portfolio
Updated 2 days ago
Overview
Price Prediction
Brokers
News
Dividend
Earnings
Innoviva News
Latest Innoviva Stock News & INVA Headlines
Is Innoviva (INVA) Stock Undervalued Right Now?
5 days
ago |
zacks.com
INVA or MRK: Which Is the Better Value Stock Right Now?
6 days
ago |
zacks.com
Innoviva (INVA) Tops Q3 Earnings Estimates
11 days
ago |
zacks.com
Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026
a month
ago |
businesswire.com
Do Options Traders Know Something About Innoviva Stock We Don't?
a month
ago |
zacks.com
INVA vs. MRK: Which Stock Is the Better Value Option?
a month
ago |
zacks.com
Should Value Investors Buy Innoviva (INVA) Stock?
a month
ago |
zacks.com
Reviewing Innoviva (NASDAQ:INVA) and 60 Degrees Pharmaceuticals (NASDAQ:SXTP)
2 months
ago |
defenseworld.net
Baird Financial Group Inc. Makes New $6.23 Million Investment in Innoviva, Inc. $INVA
2 months
ago |
defenseworld.net
Innoviva to Participate in Upcoming Investor Conferences
2 months
ago |
gurufocus.com
Load More
Download App
Keep track of your holdings and explore over 40,000 cryptocurrencies
Market Closed
INVA
Innoviva
$ 19.03
0.32%
Last 24H
Trading with leverage comes with a high risk and may not be suitable for everyone.
Trading with leverage comes with a high risk and may not be suitable for everyone.
Watchlist
Portfolio
Updated 2 days ago
People Also Watch
Top
Gainers
Losers
Symbol
Last Price
24H CNG
AAPL
$ 356.27
0.39%
NVDA
$ 162.85
-2.01%
MSFT
$ 523.88
0.17%
GOOG
$ 292.52
-0.96%
AMZN
$ 266.66
-0.29%
Explore our Tools
Watchlist
Portfolio
Alerts
Market Overview
Converter
ICO Calendar
Stocks
Never miss a story...
Subscribe to Newsletter